Nantahala-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
133
Total Value
2187261798
Accession Number
0001104659-25-049574
Form Type
13F-HR
Manager Name
Nantahala-Capital-Management
Data Enrichment
90% identified
120 identified13 unidentified

Holdings

133 positions • $2.2B total value
Manager:
Search and click to pin securities to the top
Vistagen Therapeutics, Inc.
Shares:2.0M
Value:$4.9M
% of Portfolio:0.2% ($4.9M/$2.2B)
NOODLES & Co
Shares:4.5M
Value:$4.9M
% of Portfolio:0.2% ($4.9M/$2.2B)
ALTA EQUIPMENT GROUP INC.
Shares:1.0M
Value:$4.9M
% of Portfolio:0.2% ($4.9M/$2.2B)
Xencor Inc
Shares:456.7K
Value:$4.9M
% of Portfolio:0.2% ($4.9M/$2.2B)
Fossil Group, Inc.
Shares:4.2M
Value:$4.8M
% of Portfolio:0.2% ($4.8M/$2.2B)
Inhibikase Therapeutics, Inc.
Shares:2.2M
Value:$4.8M
% of Portfolio:0.2% ($4.8M/$2.2B)
RumbleOn, Inc.
Shares:1.7M
Value:$4.8M
% of Portfolio:0.2% ($4.8M/$2.2B)
CARGO Therapeutics, Inc.
Shares:1.1M
Value:$4.5M
% of Portfolio:0.2% ($4.5M/$2.2B)
Apyx Medical Corp
Shares:3.3M
Value:$4.5M
% of Portfolio:0.2% ($4.5M/$2.2B)
ROCKET PHARMACEUTICALS, INC.
Shares:629.7K
Value:$4.2M
% of Portfolio:0.2% ($4.2M/$2.2B)
Tango Therapeutics, Inc.
Shares:3.0M
Value:$4.1M
% of Portfolio:0.2% ($4.1M/$2.2B)
Anebulo Pharmaceuticals, Inc.
Shares:3.0M
Value:$3.9M
% of Portfolio:0.2% ($3.9M/$2.2B)
Kosmos Energy Ltd.
Shares:1.7M
Value:$3.9M
% of Portfolio:0.2% ($3.9M/$2.2B)
Eledon Pharmaceuticals, Inc.
Shares:1.1M
Value:$3.9M
% of Portfolio:0.2% ($3.9M/$2.2B)
Akebia Therapeutics, Inc.
Shares:2.0M
Value:$3.8M
% of Portfolio:0.2% ($3.8M/$2.2B)
NeuroPace Inc
Shares:312.1K
Value:$3.8M
% of Portfolio:0.2% ($3.8M/$2.2B)
Rezolute, Inc.
Shares:1.3M
Value:$3.7M
% of Portfolio:0.2% ($3.7M/$2.2B)
Upstream Bio, Inc.
Shares:595.0K
Value:$3.6M
% of Portfolio:0.2% ($3.6M/$2.2B)
Dyne Therapeutics, Inc.
Shares:345.1K
Value:$3.6M
% of Portfolio:0.2% ($3.6M/$2.2B)
Astria Therapeutics, Inc.
Shares:669.5K
Value:$3.6M
% of Portfolio:0.2% ($3.6M/$2.2B)